Goldman Sachs raises China Life Insurance's target price to 33 Hong Kong dollars but maintains a "sell" rating.

Goldman Sachs released a research report stating that based on the third-quarter performance of China Life Insurance, the net profit forecasts for the years 2025 to 2027 have been raised by 38%, 13%, and 14% respectively, to reflect the significant increase in investment portfolio and book value in the previous quarter; The forecast for the book value for the fiscal years 2025 to 2027 has been raised by 10% to 13%, the forecast for new business value has been raised by 4% to 6%, and the dividend per share forecast has been raised by 40%, 15%, and 16%. Goldman Sachs has raised its target price from 30 Hong Kong dollars to 33 Hong Kong dollars and maintains a "sell" rating.